FR6453M - - Google Patents

Info

Publication number
FR6453M
FR6453M FR110092A FR110092A FR6453M FR 6453 M FR6453 M FR 6453M FR 110092 A FR110092 A FR 110092A FR 110092 A FR110092 A FR 110092A FR 6453 M FR6453 M FR 6453M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR110092A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR110092A priority Critical patent/FR6453M/fr
Application granted granted Critical
Publication of FR6453M publication Critical patent/FR6453M/fr
Priority to BE145632A priority patent/BE816573Q/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR110092A 1967-06-13 1967-06-13 Expired FR6453M (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR110092A FR6453M (fr) 1967-06-13 1967-06-13
BE145632A BE816573Q (fr) 1967-06-13 1974-06-19 Medicament a base d'un nouveau derive de pyridoxine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR110092A FR6453M (fr) 1967-06-13 1967-06-13

Publications (1)

Publication Number Publication Date
FR6453M true FR6453M (fr) 1968-11-12

Family

ID=8632871

Family Applications (1)

Application Number Title Priority Date Filing Date
FR110092A Expired FR6453M (fr) 1967-06-13 1967-06-13

Country Status (2)

Country Link
BE (1) BE816573Q (fr)
FR (1) FR6453M (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490493A1 (fr) * 1980-09-22 1982-03-26 Luso Farmaco Inst Composition pharmaceutique ou alimentaire contenant de l'a -cetoglutarate de pyridoxine, procede pour sa preparation
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6780997B2 (en) 2000-02-29 2004-08-24 Medicure International Inc. Cardioprotective phosphonates and malonates
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7115626B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490493A1 (fr) * 1980-09-22 1982-03-26 Luso Farmaco Inst Composition pharmaceutique ou alimentaire contenant de l'a -cetoglutarate de pyridoxine, procede pour sa preparation
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
US7230009B2 (en) 1999-03-08 2007-06-12 Medicure, Inc. Pyridoxal analogues and methods of treatment
US7144892B2 (en) 1999-08-24 2006-12-05 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7115626B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115625B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7125889B2 (en) 1999-08-24 2006-10-24 Medicure International Inc. Treating of cardiovascular and related pathologies
US7132430B2 (en) 1999-08-24 2006-11-07 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7148233B2 (en) 1999-08-24 2006-12-12 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US6867215B2 (en) 2000-02-29 2005-03-15 Medicure International Inc. Cardioprotective phosphonates and malonates
US7105673B2 (en) 2000-02-29 2006-09-12 Medicure International Inc. Cardioprotective phosphonates and malonates
US6780997B2 (en) 2000-02-29 2004-08-24 Medicure International Inc. Cardioprotective phosphonates and malonates
US6861439B2 (en) 2000-03-28 2005-03-01 Medicure International, Inc. Treatment of cerebrovascular disease
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Also Published As

Publication number Publication date
BE816573Q (fr) 1974-10-16

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
AU416737B2 (fr)
AU342066A (fr)
AU2277767A (fr)
AU1273466A (fr)
AU3151267A (fr)
AU2256867A (fr)
AU2116667A (fr)
AU610966A (fr)
AU2454867A (fr)
AU2977667A (fr)
AU2528767A (fr)
AU3189468A (fr)
BE693070A (fr)
BE609934A (fr)
BE692199A (fr)
AU34866A (fr)
AU408412B2 (fr)
AU25066A (fr)
AU2406369A (fr)
AU459699A (fr)
BE514578A (fr)
AU23366A (fr)
BE483855A (fr)
BE162295A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse